The BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
The measurement of these antibodies is claimed to have recently been cited as a key parameter in the definitive diagnosis of rheumatoid arthritis by the American College of Rheumatology.
The BioPlex 2200 system is an automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. The anti-CCP kit is pending clearance by the US FDA.
Phone: 0011 1 510 724 7000
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
